MGX.NASDAQMetagenomi, INC

Form 4: Metagenomi Director's Pre-Planned Stock Sale for Tax

Sentiment:

Insider Transaction Report


Metagenomi Director Brian C. Thomas executed a pre-planned sale of 2,701 common shares at $1.81 to satisfy tax withholding obligations from vested restricted stock units.

Delay expectedThe Form 4 reports a transaction that occurred on September 5, 2025, but the filing was signed on December 1, 2025, indicating a significant delay in reporting beyond the SEC's two-business-day requirement for Form 4s.

Summary

  • Brian C. Thomas, a Director of Metagenomi, Inc. (MGX), reported a transaction involving the company's common stock.
  • On September 5, 2025, Thomas disposed of 2,701 shares of common stock at a price of $1.81 per share.
  • This sale was non-volitional and executed automatically to satisfy tax withholding obligations upon the vesting of restricted stock units granted on April 1, 2024.
  • The transaction was made pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
  • Following this transaction, Thomas beneficially owns 2,514,790 shares of common stock directly.
  • The filing itself was signed on December 1, 2025, reporting a transaction that occurred on September 5, 2025.

Sentiment

Score: 5

Explanation: The transaction is a non-volitional sale of shares to cover tax withholding obligations upon RSU vesting, executed under a Rule 10b5-1 plan. This type of transaction is generally considered neutral as it does not reflect discretionary insider sentiment regarding the company's future prospects.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Minimal direct impact on shareholders as this is a routine, non-volitional transaction for tax purposes by a director, not indicative of a change in company fundamentals or insider confidence.

Key Dates

DateDescription
April 1, 2024Grant date of restricted stock units to the reporting person.
September 5, 2025Date of transaction where common stock was sold.
December 1, 2025Date the Form 4 filing was signed by the attorney-in-fact.

Keywords

Metagenomi, MGX, Form 4, Insider Transaction, Director Stock Sale, Restricted Stock Units, Tax Withholding, Rule 10b5-1 Plan, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.